Pancreatic Cancer Research

ResearcherZhongda Hospital Southeast UniversityActive in the last 2 years

Jiahua Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7664-7148; OpenAlex author ID A5102975743, A5130622118. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 11

  1. The lactate-GPR81-AMIGO2 axis promotes pancreatic ductal adenocarcinoma progression and predicts poor prognosis. Last author DOI 10.1016/j.cellsig.2026.112624↗
  2. CAFs-derived LAM332 promotes CTCs formation and survival via ITGA3 and contributes to the metastasis of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41419-026-08642-z↗
  3. Identification of prognostic immune-related genes and evaluation of chemotherapy and immunotherapy responses in pancreatic cancer. Last author DOI 10.21037/tcr-2026-1-0299↗
  4. TGFBI promotes EMT and perineural invasion of pancreatic cancer via PI3K/AKT pathway. Last author DOI 10.1007/s12032-025-02736-y↗
  5. MMA-induced LOXL2+ PSCs promote linear ECM alignment in the aging pancreas leading to pancreatic cancer progression. Last author DOI 10.1038/s41419-025-07751-5↗
  6. A five-gene prognosis model based on lysine β-hydroxybutyrylation site genes to predict the survival and therapy response in pancreatic adenocarcinoma. Last author DOI 10.1016/j.heliyon.2024.e34284↗
  7. Tiam1 Mediated Enhancement of AKT/mTOR and ERK/STAT3 Signaling Promotes Proliferation, Invasion and Migration of Pancreatic Cancer. First author PMID 39855727↗
  8. Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC. Last author DOI 10.7150/jca.62927↗
  9. Role of long intergenic non-protein coding RNA 00152 in pancreatic cancer glycolysis via the manipulation of the microRNA-185-5p/Krüppel-like factor 7 axis. Last author DOI 10.7150/jca.63128↗
  10. miRNA-339-5p Plays an Important Role in Invasion and Migration of Pancreatic Cancer Cells. Last author DOI 10.12659/msm.917038↗
  11. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation. Last author DOI 10.18632/oncotarget.18831↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zeqian Yu · 7 shared papers, 2017–2026 · strength 1.38
  2. Fangfang Hu · 2 shared papers, 2024–2026 · strength 0.56
  3. Haodong Tang · 2 shared papers, 2025–2026 · strength 0.55
  4. Yang Yang · 1 shared paper, 2026 · strength 0.50
  5. Qiannan Zhang · 1 shared paper, 2026 · strength 0.33
  6. Yamin Han · 1 shared paper, 2024 · strength 0.31
  7. Xingchao Song · 1 shared paper, 2024 · strength 0.31
  8. Siyuan Tan · 1 shared paper, 2025 · strength 0.28
  9. Wenyuan Shi · 1 shared paper, 2025 · strength 0.28
  10. Zhibin Bai · 1 shared paper, 2024 · strength 0.28
  11. Pengcheng Zhou · 1 shared paper, 2026 · strength 0.28
  12. Tonglei Xu · 1 shared paper, 2025 · strength 0.27
  13. Zheng Zhang · 1 shared paper, 2025 · strength 0.27
  14. Yang Yang · 1 shared paper, 2022 · strength 0.16
  15. Chen Hong · 1 shared paper, 2022 · strength 0.16
  16. Haifeng Li · 1 shared paper, 2021 · strength 0.13
  17. Robert M. Hoffman · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.